Activity and Immune Correlates of a Programmed Death-1 Blockade Antibody in the treatment of Refractory Solid Tumors.

about

Activity and Immune Correlates of a Programmed Death-1 Blockade Antibody in the treatment of Refractory Solid Tumors.

Item

http://www.wikidata.org/entity/Q47151168

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Activity and Immune Correlates ...... nt of Refractory Solid Tumors.

@en

Activity and Immune Correlates ...... nt of Refractory Solid Tumors.

@nl

type

Item

label

Activity and Immune Correlates ...... nt of Refractory Solid Tumors.

@en

Activity and Immune Correlates ...... nt of Refractory Solid Tumors.

@nl

prefLabel

Activity and Immune Correlates ...... nt of Refractory Solid Tumors.

@en

Activity and Immune Correlates ...... nt of Refractory Solid Tumors.

@nl

P1476

Activity and Immune Correlates ...... nt of Refractory Solid Tumors.

@en

P2093

Bei Zhang

http://www.w3.org/2001/XMLSchema#string

Chang Jiang

http://www.w3.org/2001/XMLSchema#string

Hongxia Zhang

http://www.w3.org/2001/XMLSchema#string

Liangping Xia

http://www.w3.org/2001/XMLSchema#string

Xiaojun Xia

http://www.w3.org/2001/XMLSchema#string

Xiuyu Cai

http://www.w3.org/2001/XMLSchema#string

P2860

Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade.

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma

Immune Checkpoint Blockade in Cancer Therapy

Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma

The blockade of immune checkpoints in cancer immunotherapy

Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

P304

205-212

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.7150/JCA.21414

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29290787

http://www.w3.org/2001/XMLSchema#string

P932

5743729

http://www.w3.org/2001/XMLSchema#string